LY3200882 (Standard)

Overview

LY3200882 (Standard) is the analytical standard of LY3200882 ( HY-103021 ). This product is intended for research and analytical applications. LY3200882 is a potent, highly selective, ATP-competitive and orally active TGF-β receptor type 1 ( ALK5 ) inhibitor with an IC 50 of 38.2 nM. LY3200882 inhibits various pro-tumorigenic activities and is also used as an immune modulatory agent.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > TGF-β Receptor

Product Information

• Catalog No.: HY-103021R
• CAS No.: 1898283-02-7
• Molecular Formula: C24H29N5O3
• Molecular Weight: 435.52
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source